Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

949 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group.
Cameron DA, Craig J, Gabra H, Lee L, MacKay J, Parker AC, Leonard RC, Anderson E, Anderson T, Chetty U, Dixon M, Hawkins A, Jack W, Kunkler I, Leonard R, Matheson L, Miller W. Cameron DA, et al. Among authors: leonard rc, leonard r. Br J Cancer. 1996 Dec;74(12):2013-7. doi: 10.1038/bjc.1996.669. Br J Cancer. 1996. PMID: 8980406 Free PMC article. Clinical Trial.
The endocrine environment.
Leonard R. Leonard R. Eur J Cancer Care (Engl). 1996 Sep;5(3 Suppl):1. doi: 10.1111/j.1365-2354.1996.tb00252.x. Eur J Cancer Care (Engl). 1996. PMID: 9117054 No abstract available.
TEXAS (Taxotere EXperience with Anthracyclines Study) trial: mature results of activity/toxicity of docetaxel given with anthracyclines in a community setting, as first line therapy for MBC.
Malinovszky K, Johnston S, Barrett-Lee P, Howell A, Verrill M, O'Reilly S, Houston S, Wardley A, Grieve R, Leonard R. Malinovszky K, et al. Among authors: leonard r. Cancer Chemother Pharmacol. 2007 Feb;59(3):413-8. doi: 10.1007/s00280-006-0303-9. Epub 2006 Sep 29. Cancer Chemother Pharmacol. 2007. PMID: 17009036 Clinical Trial.
Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study.
Blagden SP, Rizzuto I, Suppiah P, O'Shea D, Patel M, Spiers L, Sukumaran A, Bharwani N, Rockall A, Gabra H, El-Bahrawy M, Wasan H, Leonard R, Habib N, Ghazaly E. Blagden SP, et al. Among authors: leonard r. Br J Cancer. 2018 Oct;119(7):815-822. doi: 10.1038/s41416-018-0244-1. Epub 2018 Sep 12. Br J Cancer. 2018. PMID: 30206366 Free PMC article. Clinical Trial.
A prognostic index for operable, node-negative breast cancer.
McCallum M, Baker C, Gillespie K, Cohen B, Stewart H, Leonard R, Cameron D, Leake R, Paxton J, Robertson A, Purdie C, Gould A, Steel M. McCallum M, et al. Among authors: leonard r. Br J Cancer. 2004 May 17;90(10):1933-41. doi: 10.1038/sj.bjc.6601826. Br J Cancer. 2004. PMID: 15138474 Free PMC article.
949 results